TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
NRIX

Nurix Therapeutics Inc

Healthcare · Biotechnology

22.60$ -1.2% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement NRIX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– -16.9% -42.7% +66.9% +29.8% +99.3% -29.1% +54.0%
– +11.1% +47.7% -90.9% +77.7% +1,650.1% +17.2% -91.5%
– – – +66.9% +29.8% -390.4% – –
– +11.1% +47.7% +75.1% +58.5% +2.5% +17.2% +39.0%
– +24.8% +95.9% +91.3% +21.8% +12.9% +7.1% +14.8%
– +24.8% +894.5% +78.3% +50.7% -80.7% +7.1% +663.5%
– – – – – – – –
– -5.1% +336.3% +103.9% +107.3% – – –
– – – – – – – –
– -52.9% -8,692.1% – -11,027.5% – -98.0% +181.5%
– – – – – – – –
– – – – – – – –

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?